3 hasil untuk "Anna Burguin"
Menampilkan 1–3 · 2,84 detik · RSS
-
Artikel Jurnal Teks lengkap
Breast Cancer Treatments: Updates and New Challenges
Breast cancer (BC) is the most frequent cancer diagnosed in women worldwide. This heterogeneous disease can be classified into four molecular subtypes (luminal A, luminal B, HER2 and triple-negative breast cancer (TNBC)) according to the expression of the estrogen receptor (ER) and the progesterone…
-
Artikel Jurnal Teks lengkap
Trastuzumab effects depend on HER2 phosphorylation in HER2-negative breast cancer cell lines.
The breast cancer (BC) biomarker HER2 (Human Epidermal Receptor 2) is overexpressed in 25% of BC. Only patients with HER2-positive tumors receive HER2-targeting therapies, like trastuzumab (Herceptin). However, some women with a HER2-negative BC could benefit from trastuzumab. This could be…
Juga tersedia di: PLOS